Note: This article is written for general educational purposes and reflects U.S. guidance available as of May 29, 2026. COVID-19 vaccine recommendations can change by season, variant, age group, health status, insurance rules, and state pharmacy policy. Readers should confirm personal eligibility with a healthcare professional, pharmacist, local health department, or current CDC guidance before making a medical decision.
“Who is eligible for a COVID-19 booster?” sounds like a simple question, the kind you might ask while standing in line at the pharmacy between cough drops and a suspiciously expensive bottle of hand sanitizer. But in the United States, the answer has become more nuanced than it was during the early pandemic years. Today, many people still say “booster,” but the more accurate term is often “updated COVID-19 vaccine” because the shot is revised for newer circulating strains, much like the flu vaccine gets a seasonal wardrobe change.
The short answer is this: for the 2025–2026 season, CDC guidance recommends a COVID-19 vaccine for people ages 6 months and older using individual-based decision-making, also called shared clinical decision-making. That means the decision should consider age, health risks, prior vaccination, recent infection, exposure risk, pregnancy status, immune status, and personal preference. The strongest emphasis is on people most likely to benefit: adults 65 and older, people with medical conditions that increase the risk of severe COVID-19, residents of long-term care facilities, people who are moderately or severely immunocompromised, pregnant people, and those who have never received a COVID-19 vaccine.
COVID-19 Booster Eligibility: The Big Picture
Eligibility is no longer just a blanket “everyone line up, sleeves up” announcement. Instead, the current U.S. approach has three layers: who is recommended by CDC guidance, who is covered under FDA-approved vaccine labels, and who can practically access the shot at a clinic or pharmacy. That last part matters because real life enjoys adding paperwork to everything, including public health.
CDC guidance says the updated 2025–2026 COVID-19 vaccine is recommended for people ages 6 months and older based on individual decision-making. For adults 65 and older, the case is especially strong because age remains the biggest risk factor for severe COVID-19 outcomes. For people under 65, the benefit is usually greatest when they have risk factors such as chronic disease, pregnancy, immunocompromise, disability, obesity, diabetes, heart disease, lung disease, kidney disease, cancer, or regular close contact with medically vulnerable people.
FDA vaccine labels are more specific by product. For example, Moderna Spikevax is approved for people 65 and older and for people ages 6 months through 64 years with at least one underlying condition that raises the risk of severe COVID-19. Pfizer-BioNTech Comirnaty is approved for people 65 and older and for people ages 5 through 64 years with at least one high-risk condition. Moderna mNexspike and Novavax Nuvaxovid are approved for people 65 and older and for people ages 12 through 64 years with at least one high-risk condition.
Who Should Most Strongly Consider an Updated COVID-19 Vaccine?
Adults 65 and Older
Adults age 65 and older are among the clearest candidates for an updated COVID-19 vaccine. The immune system changes with age, and the risk of hospitalization, intensive care, and death rises sharply in older adulthood. For this group, CDC guidance indicates two doses of a 2025–2026 COVID-19 vaccine during the season, generally spaced 6 months apart. A shorter minimum interval may apply in certain situations, depending on the product used and clinical need.
A practical example: a 72-year-old who received a 2025–2026 COVID-19 vaccine in October may be advised to receive another dose around April, especially if they live with chronic illness, spend time in group settings, or want extra protection before travel or family gatherings. Yes, family gatherings count as exposure events. Aunt Linda may bring pie, but she may also bring a cough she calls “just allergies.”
People With Medical Conditions That Increase COVID-19 Risk
People ages 6 months through 64 years with certain underlying medical conditions are also important candidates. CDC’s list of higher-risk conditions includes many common diagnoses, such as asthma, cancer, chronic kidney disease, chronic lung disease, diabetes, heart conditions, obesity, pregnancy and recent pregnancy, smoking history, solid organ or blood stem cell transplant, use of corticosteroids or other immunosuppressive medicines, and certain neurologic, liver, mental health, or immune-related conditions.
The list is not meant to be a velvet rope at a nightclub. It is not exhaustive, and CDC guidance says people can self-attest to risk factors. In plain English: if you have a condition that increases your risk, you should not be denied vaccination simply because you did not bring a folder of medical records to the pharmacy counter.
People Who Are Moderately or Severely Immunocompromised
People who are moderately or severely immunocompromised often need a more customized vaccination plan. This group may include people receiving cancer treatment, people with organ or stem cell transplants, people taking immune-suppressing medications, people with advanced or untreated HIV, and people with certain primary immune deficiencies.
For immunocompromised people, CDC guidance recommends updated vaccination and allows additional doses after discussion with a healthcare provider. In many cases, additional doses may be given at least 2 months after the last updated COVID-19 vaccine dose. The exact number of doses depends on age, vaccine history, immune status, and medical timing, such as chemotherapy cycles or transplant care. This is one area where “ask your doctor” is not a throwaway line; it is genuinely the best route.
Pregnant, Recently Pregnant, or Breastfeeding People
Pregnancy increases the risk of severe COVID-19. People who are pregnant or recently pregnant have higher chances of hospitalization and complications if infected. CDC guidance now uses individual decision-making language for the 2025–2026 vaccine, but it also notes that vaccination offers the greatest benefit for people at higher risk, including pregnant people. Several professional medical organizations continue to support COVID-19 vaccination during pregnancy and lactation because protection can benefit both the pregnant person and, indirectly, the baby.
For readers trying to become pregnant, the key point is simple: COVID-19 vaccines are not associated with fertility problems in women or men. For breastfeeding parents, available guidance supports vaccination, and breastfeeding does not need to be paused because of a COVID-19 shot.
Residents and Staff in Long-Term Care or Congregate Settings
People living in nursing homes, assisted living facilities, group homes, shelters, or other congregate settings may face higher exposure risk. Residents of long-term care facilities are especially vulnerable because age, chronic illness, and close-contact living often overlap. Staff members may also consider vaccination because they move between households, workplaces, and high-risk residents.
COVID-19 Booster Eligibility by Age
Children Ages 6 Months to 4 Years
Young children can be eligible for updated COVID-19 vaccination, but product choices and dose schedules are more specific than they are for adults. For the 2025–2026 season, Moderna Spikevax is the main option for children under age 5. Unvaccinated infants ages 6 through 23 months may need a two-dose initial series, while children who previously received COVID-19 vaccines may need fewer doses. Children ages 2 through 4 generally receive one updated dose, depending on previous vaccination history.
Parents should discuss the decision with a pediatrician or qualified healthcare professional. This is especially important for children with prematurity history, chronic lung disease, heart disease, diabetes, immune problems, neurologic conditions, or household contact with someone at high risk.
Children Ages 5 to 11
Children ages 5 to 11 may receive an age-appropriate updated COVID-19 vaccine. Pfizer-BioNTech Comirnaty and Moderna Spikevax are the main products available for this age group. For most children in this age band, one updated dose is the basic schedule, but children who are immunocompromised may need a different plan.
Teens and Adults Ages 12 to 64
People ages 12 through 64 have several possible vaccine options depending on risk status and product availability, including Moderna Spikevax, Moderna mNexspike, Pfizer-BioNTech Comirnaty, and Novavax Nuvaxovid. For many people in this age group, one updated dose is the usual seasonal approach. People with high-risk conditions, immune compromise, pregnancy, or high exposure should discuss the benefits with a healthcare provider or pharmacist.
For healthy adults under 65, the answer may be less automatic than in earlier years. CDC uses shared clinical decision-making language, while FDA product labels focus on adults 65 and older and younger people with high-risk conditions. In practical terms, a healthy 30-year-old may need to check local rules, pharmacy policy, insurance coverage, and clinician guidance. A 30-year-old with asthma, diabetes, obesity, cancer history, pregnancy, or immune suppression has a much clearer reason to consider vaccination.
Adults 65 and Older
Adults 65 and older are eligible and strongly prioritized. The current schedule generally calls for two doses during the 2025–2026 season, spaced about 6 months apart. This reflects the reality that protection can decrease over time and that COVID-19 does not follow one tidy winter-only pattern. It can rise in waves, including during summer and winter, because apparently one season of respiratory drama was not enough.
What If You Recently Had COVID-19?
If you recently had COVID-19, you may be able to delay vaccination for about 3 months from when symptoms started or, if you had no symptoms, from the date of your positive test. This is because infection can provide some short-term immune protection. However, waiting is not always the best choice for everyone. People at higher risk of severe illness, people who live with vulnerable family members, or people in areas with high COVID-19 activity may choose to get vaccinated sooner after recovery.
One universal rule still applies: if you are currently moderately or severely ill, wait until you recover before getting vaccinated. Nobody wins a prize for getting a vaccine while feverish, dehydrated, and wondering whether soup counts as a personality.
Which COVID-19 Vaccines Are Available?
The United States has several 2025–2026 COVID-19 vaccine options. Moderna Spikevax is approved for older adults and for younger people at high risk, starting at age 6 months. Pfizer-BioNTech Comirnaty is approved for older adults and for younger high-risk people starting at age 5. Moderna mNexspike is approved for older adults and high-risk people starting at age 12. Novavax Nuvaxovid is a protein-based option approved for older adults and high-risk people starting at age 12.
There is no universal “best” COVID-19 vaccine for everyone. The best choice depends on age, availability, medical history, prior vaccine reactions, immune status, and whether someone prefers an mRNA vaccine or a protein-based vaccine. For many people, the most practical vaccine is the one that is age-appropriate, recommended for their situation, available nearby, and accepted by their healthcare provider.
Common Eligibility Examples
Example 1: A 68-year-old retiree. This person is eligible and should strongly consider vaccination. They may be advised to receive two seasonal doses, spaced about 6 months apart.
Example 2: A 42-year-old with asthma and diabetes. This person is under 65 but has conditions that increase risk. They are a strong candidate for an updated COVID-19 vaccine.
Example 3: A healthy 25-year-old who works with the public. This person may still discuss vaccination through shared decision-making, but access and coverage may depend on local rules, pharmacy policy, insurance, and clinician judgment.
Example 4: A pregnant 31-year-old. Pregnancy is a risk factor for severe COVID-19. This person should discuss vaccination with an obstetric clinician, midwife, pharmacist, or healthcare provider.
Example 5: A 10-year-old with no health problems. Parents should speak with the child’s pediatrician. Eligibility and recommendations for children involve age, health risk, prior vaccination, household risk, and current professional guidance.
Example 6: A transplant recipient. This person should work with their specialist because immunocompromised people may need additional doses and careful timing around treatment.
Why Boosters Still Matter
COVID-19 vaccines are not magic force fields. You can still get infected after vaccination, just as an umbrella does not prevent rain from existing. But vaccination can reduce the risk of severe illness, hospitalization, death, and possibly Long COVID. Protection can fade over time, and the virus keeps changing, which is why updated vaccines continue to matter for people at higher risk.
For older adults and immunocompromised people, the goal is not just avoiding a positive test. The bigger goal is staying out of the hospital, avoiding complications, preserving independence, and reducing the chance that a respiratory infection turns into a major medical event. That is why booster eligibility is really a risk conversation, not just a calendar reminder.
Real-World Experiences: What Eligibility Feels Like in Everyday Life
In real life, the COVID-19 booster question rarely arrives as a clean spreadsheet. It shows up as a text from a parent asking, “Do I need another shot?” It appears when a daughter tries to schedule a vaccine for her 81-year-old father before Thanksgiving. It pops up when a pregnant teacher wonders whether being around 24 sniffly second-graders every weekday counts as “higher risk.” Spoiler: it certainly feels like a full-contact sport.
One common experience is confusion at the pharmacy. A person may read that CDC guidance allows vaccination through individual decision-making, but the pharmacy website may ask whether they are 65 or older or have a high-risk condition. That mismatch can feel frustrating. The reason is that CDC recommendations, FDA product labels, state rules, insurance policies, and pharmacy protocols do not always speak in the same friendly language. A good approach is to call ahead, ask what documentation is required, and explain your risk factor clearly. In many cases, self-attestation is enough, but policies may vary.
Another experience involves families making decisions together. An adult child may be less worried about themselves but very concerned about visiting an older parent receiving chemotherapy. In that situation, vaccination may be part of a broader protection plan: staying home when sick, testing before visits, improving ventilation, wearing a mask in crowded indoor spaces, and making sure the high-risk person has a treatment plan if symptoms appear. The vaccine is important, but it is not the only tool in the toolbox.
Parents often describe a different kind of uncertainty. They want to protect their children, but they also want clear advice. For infants, toddlers, and children with underlying conditions, the conversation with a pediatrician can be especially helpful. Parents can ask: “Is my child at higher risk?” “Which vaccine product is available for this age?” “How many doses are needed?” “Should we time this around flu vaccination or an upcoming trip?” Practical questions often lead to better decisions than vague internet panic, which has never improved anyone’s blood pressure.
For older adults, the experience is usually more straightforward. Many already receive annual flu shots and may be used to asking about vaccines during routine appointments. The key is timing. Someone 65 or older may need two COVID-19 vaccine doses in the season, not just one. A calendar reminder can help: first dose in the fall, second dose about 6 months later, adjusted for medical advice and local COVID-19 activity.
For immunocompromised people, the experience can be more personal and more urgent. A patient on immune-suppressing therapy may not respond to vaccines as strongly as others, but that does not mean vaccination is pointless. It means the plan may need to be layered and individualized. Some patients coordinate vaccine timing with specialists so the immune system has the best possible chance to respond. Others combine vaccination with masking, early testing, and quick access to antiviral treatment if infected.
The most useful lesson from these everyday experiences is this: eligibility is not just about checking a box. It is about matching the vaccine decision to the person’s actual risk, exposure, medical history, and goals. A healthy remote worker and a nursing home resident do not face the same risk. A college athlete and a kidney transplant recipient do not need the same conversation. The best booster decision is not the loudest one on social media; it is the one made with current information and calm, practical judgment.
Conclusion
So, who is eligible for a COVID-19 booster? In the United States, the clearest answer is that adults 65 and older, people with high-risk medical conditions, immunocompromised people, pregnant or recently pregnant people, and residents of long-term care settings should strongly consider an updated COVID-19 vaccine. CDC guidance also allows people ages 6 months and older to consider vaccination through individual decision-making, while FDA product labels and real-world access rules may vary by age, risk status, vaccine brand, insurance, and location.
The smartest move is to treat booster eligibility as a personal risk checkup. Ask: Am I older? Do I have a condition that raises my risk? Am I pregnant? Do I live with or care for someone vulnerable? Have I recently had COVID-19? Am I immunocompromised? Do I have travel, work, school, or family exposure coming up? The answers will point you toward the right decision faster than scrolling through 47 comment threads written by people whose medical credentials are “very confident.”
